Literature DB >> 8338989

Adenovirus type 7h respiratory infections: a report of 29 cases of acute lower respiratory disease.

P Murtagh1, C Cerqueiro, A Halac, M Avila, A Kajon.   

Abstract

Twenty-nine cases of pediatric acute lower respiratory disease associated with adenovirus genome type 7h were evaluated retrospectively. They constituted 2.4% of 1233 cases of acute respiratory infections treated in five hospitals in Buenos Aires, between September 1984 and September 1988. Pneumonia and bronchiolitis were the principal diagnoses. The mean age of patients was 8.8 months and 82.7% of the children were less than one year of age. None of the patients had previously been exposed to measles or was immunocompromised. A mixed infection, viral or bacterial, was demonstrated in 8 of the 29 patients. Sixteen children developed a severe pulmonary disease which required intensive care. Ten with a clinical diagnosis of multifocal pneumonia and necrotizing bronchiolitis died. Extrapulmonary manifestations were observed in the most severe cases. Observations suggest a possible high pathogenicity of adenovirus type 7h and emphasize the need for adequate control and case management programs.

Entities:  

Mesh:

Year:  1993        PMID: 8338989     DOI: 10.1111/j.1651-2227.1993.tb12753.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  15 in total

1.  Use of PCR to demonstrate presence of adenovirus species B, C, or F as well as coinfection with two adenovirus species in children with flu-like symptoms.

Authors:  Marcela Echavarria; Daniela Maldonado; Gabriela Elbert; Cristina Videla; Ruth Rappaport; Guadalupe Carballal
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

2.  Growth in post-viral chronic lung disease.

Authors:  Mariana del Pino; Gabriela Bauer; Hebe González Pena; Mario Grenoville; Horacio Lejarraga
Journal:  Eur J Pediatr       Date:  2006-06-15       Impact factor: 3.183

3.  Genome analysis of South American adenovirus strains of serotype 7 collected over a 7-year period.

Authors:  A Kajon; G Wadell
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

4.  Quantitation of adenovirus genome during acute infection in normal children.

Authors:  Hiroko Shike; Chisato Shimizu; John Kanegaye; Jennifer L Foley; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2005-01       Impact factor: 2.129

5.  Five genome sequences of subspecies B1 human adenoviruses associated with acute respiratory disease.

Authors:  Shoaleh Dehghan; Elizabeth B Liu; Jason Seto; Sarah F Torres; Nolan R Hudson; Adriana E Kajon; David Metzgar; David W Dyer; James Chodosh; Morris S Jones; Donald Seto
Journal:  J Virol       Date:  2012-01       Impact factor: 5.103

6.  Human adenovirus type 7 infection associated with severe and fatal acute lower respiratory illness and nosocomial transmission.

Authors:  Xianyan Cui; Liang Wen; Zhihao Wu; Nan Liu; Chaojie Yang; Wei Liu; Zhongwei Ba; Jian Wang; Shengjie Yi; Hao Li; Beibei Liang; Peng Li; Leili Jia; Rongzhang Hao; Ligui Wang; Yuejin Hua; Yong Wang; Shaofu Qiu; Hongbin Song
Journal:  J Clin Microbiol       Date:  2014-12-17       Impact factor: 5.948

7.  Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon.

Authors:  M Narita; H Tanaka; S Abe; S Yamada; M Kubota; T Togashi
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 8.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Epitopes and hemagglutination binding domain on subgenus B:2 adenovirus fibers.

Authors:  Y F Mei; G Wadell
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  No evidence of a death-like function for species B1 human adenovirus type 3 E3-9K during A549 cell line infection.

Authors:  Kathryn M Frietze; Samuel K Campos; Adriana E Kajon
Journal:  BMC Res Notes       Date:  2012-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.